VAERS Explorer
Back to explore

Report #2847730

Received Jul 9, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
51 yrs
State
TX
Recovered
Unknown
Vaccinated
Jun 27, 2025
Onset
Jun 28, 2025
Days to onset
1
Hospital days
—

Vaccines (4)

TypeNameManufacturerDoseLotRoute / Site
PNC21PNEUMO (CAPVAXIVE)MERCK & CO. INC.1Y019158IM / RA
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1PJ353IM / RA
PNC21PNEUMO (CAPVAXIVE)MERCK & CO. INC.UNKUNK—
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (7)

DizzinessHypersensitivityRashRash erythematousVision blurredFatigueRash papular

Symptom narrative

Rash/rashes behind his ears, and on his neck on the right side/entire face, forehead and cheeks; Redness/redness spread to his other side, entire face, forehead and cheeks; Swelling; Tiredness; This non-serious case was reported by a consumer via call center representative and described the occurrence of rash in a 51-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Pneumococcal vaccine conj 21v (CRM197) (Capvaxive) for prophylaxis. On 27-JUN-2025, the patient received Shingrix and Capvaxive. On 28-JUN-2025, 1 days after receiving Shingrix and Capvaxive, the patient experienced rash (Verbatim: Rash/rashes behind his ears, and on his neck on the right side/entire face, forehead and cheeks), erythema (Verbatim: Redness/redness spread to his other side, entire face, forehead and cheeks), swelling (Verbatim: Swelling) and tiredness (Verbatim: Tiredness). The outcome of the rash, erythema, swelling and tiredness were unknown. It was unknown if the reporter considered the rash, erythema, swelling and tiredness to be related to Shingrix and Capvaxive. It was unknown if the company considered the rash, erythema, swelling and tiredness to be related to Shingrix and Capvaxive. Additional Information: GSK Receipt Date: 30-JUN-2025 The patient who received his first dose of Shingrix and Capvaxive last Friday on 27 Jun 2025. He stated that the next day on 28 Jun 2025, he had rashes behind his ears, and on his neck on the right side. It was also swollen and red. The rash and redness spread to his other side, entire face, forehead and cheeks. His pharmacy instructed him to take Benadryl.